awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30911112-447BACFC-F3FB-424D-A972-3052E12C0211
Q30911112-447BACFC-F3FB-424D-A972-3052E12C0211
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30911112-447BACFC-F3FB-424D-A972-3052E12C0211
The maraviroc expanded access program - safety and efficacy data from an open-label study.
P2860
Q30911112-447BACFC-F3FB-424D-A972-3052E12C0211
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30911112-447BACFC-F3FB-424D-A972-3052E12C0211
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
97294f66cc68861ac5e671b6399e97e2be97c71d
P2860
A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations